|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 83.20 USD | +0.54% |
|
+15.69% | +1.62% |
| 08-12 | Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating | MT |
| 08-07 | Mizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating | MT |
| Market Cap | 3.65B 3.14B 2.95B 2.7B 5.03B 345B 5.07B 34.87B 13.58B 176B 13.71B 13.41B 568B | P/E 2026 * |
-39x | P/E 2027 * | 35.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.65B 3.14B 2.95B 2.7B 5.03B 345B 5.07B 34.87B 13.58B 176B 13.71B 13.41B 568B | EV / Sales 2026 * |
5.12x | EV / Sales 2027 * | 3.95x |
| Free-Float |
97.13% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TARS | Delayed | |
CBOE
| TARS | Real-time |
Last Transcript : Tarsus Pharmaceuticals, Inc.
| 1 day | +0.54% | ||
| 1 week | +15.69% | ||
| Current month | +12.08% | ||
| 1 month | +35.69% | ||
| 3 months | +41.60% | ||
| 6 months | +8.69% | ||
| Current year | +1.62% |
| 1 week | 70.71 |  | 84.5 |
| 1 month | 57.63 | | 84.5 |
| Current year | 53.89 | | 84.5 |
| 1 year | 48.2 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 2018-08-31 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 2023-04-23 |
| Chief Tech/Sci/R&D Officer | 47 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 2022-12-01 |
| Director/Board Member | 71 | 2019-11-30 | |
Bill Link
BRD | Director/Board Member | 80 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/24/26 | Exercice | Director | 2,766 | 0.0065% | ||
| 3/20/26 | Sell | Chief Operating Officer | 2,989 | 0.0070% | ||
| 3/17/26 | Sell | Head of Human Resources | 12,274 | 0.0288% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.54% | +15.69% | +44.15% | +399.43% | 3.63B | |
| -1.00% | +4.43% | +49.60% | +1.42% | 85.08B | |
| -1.29% | +4.27% | +519.00% | +32.26% | 60.21B | |
| -0.52% | +1.31% | -17.21% | -34.97% | 59.71B | |
| -1.60% | -7.34% | -5.08% | +31.05% | 51.1B | |
| +0.09% | -0.54% | +9.26% | +165.71% | 48.73B | |
| +0.83% | +1.36% | +58.53% | -15.97% | 32.9B | |
| -0.64% | +0.20% | +47.19% | +97.87% | 26.11B | |
| +0.19% | -3.91% | +3.20% | +199.42% | 22.6B | |
| +1.10% | -1.67% | +64.17% | +118.01% | 16.42B | |
| Average | -0.18% | +1.48% | +77.28% | +99.42% | 40.65B | |
| Weighted average by Cap. | -0.56% | +0.86% | +96.13% | +48.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 714M 614M 576M 527M 984M 67.46B 992M 6.82B 2.65B 34.47B 2.68B 2.62B 111B | 925M 796M 747M 684M 1.28B 87.47B 1.29B 8.84B 3.44B 44.7B 3.47B 3.4B 144B |
| Net income | -95.74M -82.37M -77.3M -70.72M -132M -9.05B -133M -914M -356M -4.62B -360M -352M -14.9B | 116M 99.73M 93.59M 85.63M 160M 10.96B 161M 1.11B 431M 5.6B 435M 426M 18.03B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | US$83.21 | +0.54% | 733,663 |
| 26-09-02 | US$82.76 | +11.76% | 1,899,864 |
| 26-09-01 | US$74.05 | -0.26% | 587,273 |
| 26-08-31 | US$74.24 | +3.46% | 711,972 |
| 26-08-28 | US$71.76 | -0.22% | 615,743 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
